Found: 58
Select item for more details and to access through your institution.
The Lyon Consensus: Does It Differ From the Previous Ones?
- Published in:
- Journal of Neurogastroenterology & Motility, 2020, v. 26, n. 3, p. 311, doi. 10.5056/jnm20046
- By:
- Publication type:
- Article
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 2011, doi. 10.3390/jcm9062011
- By:
- Publication type:
- Article
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 5, p. 559, doi. 10.3390/life14050559
- By:
- Publication type:
- Article
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 95, doi. 10.1111/apt.16923
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: artificial intelligence in the diagnosis of oesophageal diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 528, doi. 10.1111/apt.16778
- By:
- Publication type:
- Article
Editorial: will clusters for anxiety, depression, sleep disturbance and fatigue symptoms predict treatment outcomes in functional dyspepsia? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 5, p. 652, doi. 10.1111/apt.16247
- By:
- Publication type:
- Article
Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 253, doi. 10.1111/apt.16184
- By:
- Publication type:
- Article
Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 273, doi. 10.1111/apt.16167
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 5, p. 762, doi. 10.1111/apt.16006
- By:
- Publication type:
- Article
Editorial: minesapride for irritable bowel syndrome with constipation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 713, doi. 10.1111/apt.15941
- By:
- Publication type:
- Article
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data.
- Published in:
- Clinical & Experimental Gastroenterology, 2020, v. 13, p. 99, doi. 10.2147/CEG.S228352
- By:
- Publication type:
- Article
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 3, p. 387, doi. 10.1159/000528070
- By:
- Publication type:
- Article
Real-Life Comparison of Different Anti-TNF Biologic Therapies for Ulcerative Colitis Treatment: A Retrospective Cohort Study.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 1, p. 16, doi. 10.1159/000508865
- By:
- Publication type:
- Article
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1539, doi. 10.3390/jcm13061539
- By:
- Publication type:
- Article
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3270, doi. 10.3390/jcm10153270
- By:
- Publication type:
- Article
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3824, doi. 10.3390/cancers15153824
- By:
- Publication type:
- Article
The Risk of Malignancies in Celiac Disease—A Literature Review.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5288, doi. 10.3390/cancers13215288
- By:
- Publication type:
- Article
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3162, doi. 10.3390/cancers13133162
- By:
- Publication type:
- Article
Prevention Strategies for Esophageal Cancer—An Expert Review.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2183, doi. 10.3390/cancers13092183
- By:
- Publication type:
- Article
Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2020, p. 1, doi. 10.1177/1756284820934315
- By:
- Publication type:
- Article
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation.
- Published in:
- Intestinal Research, 2022, v. 20, n. 1, p. 114, doi. 10.5217/ir.2021.00037
- By:
- Publication type:
- Article
Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Gastro-esophageal diagnostic workup before bariatric surgery or endoscopic treatment for obesity: position statement of the International Society of Diseases of the Esophagus.
- Published in:
- Diseases of the Esophagus, 2024, v. 37, n. 5, p. 1, doi. 10.1093/dote/doae006
- By:
- Publication type:
- Article
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94685-5
- By:
- Publication type:
- Article
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89790-4
- By:
- Publication type:
- Article
Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 12 months of longitudinal follow‐up.
- Published in:
- Neurogastroenterology & Motility, 2024, v. 36, n. 2, p. 1, doi. 10.1111/nmo.14713
- By:
- Publication type:
- Article
Comparison of acid‐lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta‐Analysis.
- Published in:
- Neurogastroenterology & Motility, 2023, v. 35, n. 1, p. 1, doi. 10.1111/nmo.14469
- By:
- Publication type:
- Article
Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis.
- Published in:
- Neurogastroenterology & Motility, 2022, v. 34, n. 6, p. 1, doi. 10.1111/nmo.14279
- By:
- Publication type:
- Article
Efficacy of teduglutide in a patient with Crohn's disease and short bowel syndrome on enteral nutrition: let's start to think out of the box.
- Published in:
- Gastroenterology Report, 2019, v. 7, n. 6, p. 459, doi. 10.1093/gastro/goz030
- By:
- Publication type:
- Article
Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 19, p. 2140, doi. 10.3390/diagnostics14192140
- By:
- Publication type:
- Article
Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 17, p. 2806, doi. 10.3390/diagnostics13172806
- By:
- Publication type:
- Article
Vonoprazan May Provide Better Results than PPIs in Helicobacter Pylori Eradication and Beyond -- Is it Time for a Change?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Impact of inflammatory bowel disease on women's reproductive life: a questionnaire-based study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241249440
- By:
- Publication type:
- Article
Eosinophilic esophagitis: from pathophysiology to management.
- Published in:
- Minerva Gastroenterology, 2022, v. 68, n. 1, p. 40, doi. 10.23736/S2724-5985.20.02780-4
- By:
- Publication type:
- Article
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e118, doi. 10.1093/oncolo/oyad238
- By:
- Publication type:
- Article
Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820936536
- By:
- Publication type:
- Article
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820934589
- By:
- Publication type:
- Article
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820934315
- By:
- Publication type:
- Article
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 7, p. 1097, doi. 10.1093/ecco-jcc/jjad030
- By:
- Publication type:
- Article
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 12, p. 1845, doi. 10.1093/ecco-jcc/jjac094
- By:
- Publication type:
- Article
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1070, doi. 10.1093/ecco-jcc/jjac010
- By:
- Publication type:
- Article
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 7, p. 1184, doi. 10.1093/ecco-jcc/jjab010
- By:
- Publication type:
- Article
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 5, p. 733, doi. 10.1093/ecco-jcc/jjaa226
- By:
- Publication type:
- Article
The Role of the FODMAP Diet in IBS.
- Published in:
- Nutrients, 2024, v. 16, n. 3, p. 370, doi. 10.3390/nu16030370
- By:
- Publication type:
- Article
Myths and Facts about Food Intolerance: A Narrative Review.
- Published in:
- Nutrients, 2023, v. 15, n. 23, p. 4969, doi. 10.3390/nu15234969
- By:
- Publication type:
- Article
A Survey on Nutritional Knowledge in Coeliac Disease Compared to Inflammatory Bowel Diseases Patients and Healthy Subjects.
- Published in:
- Nutrients, 2020, v. 12, n. 4, p. 1110, doi. 10.3390/nu12041110
- By:
- Publication type:
- Article
Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231188549
- By:
- Publication type:
- Article
Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231188549
- By:
- Publication type:
- Article
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023384
- By:
- Publication type:
- Article